Business Wire

Megaport Announces Strategic Partnership With Bechtle as Network as a Service (NaaS) Vendor Partner

4.5.2022 01:00:00 EEST | Business Wire | Press release

Share

Megaport Limited (ASX: MP1) ("Megaport"), a global leading Network as a Service (NaaS) provider, announced it has entered into a distribution agreement with Bechtle, Germany’s largest IT system house and a leading IT e-commerce provider in Europe. The agreement will make Megaport’s global, private Software Defined Network (SDN) platform available through Bechtle to companies looking to modernise their networks and accelerate digital transformation.

“Bringing Megaport’s leading NaaS platform into the Bechtle portfolio makes it easier for customers to modernise their network connectivity and connect quickly to leading cloud service providers,” said Rodney Foreman, Chief Revenue Officer at Megaport. “Whether customers are addressing multicloud architectures, bridging SD-WAN to cloud, or enabling hybrid environments, Megaport’s platform makes it easy to securely and rapidly connect critical IT services. Bechtle’s European footprint and reach, combined with their expertise in IT solutions, makes them ideal to expand and deepen our channel relationships.”

“With Megaport, we are expanding our portfolio with innovative and scalable IaaS-solutions that are required by today’s competitive companies,” explained Ralf Beck, Director Software Product Management Infrastructure at Bechtle. “The provision of services by German data centres and the connectivity to leading cloud providers round off Megaport’s range of service.”

By using Megaport, Bechtle customers can enjoy the following benefits:

  • Improved network performance with reduced jitter and latency.
  • Reduced cloud egress costs to cloud on-ramps when compared to internet rates.
  • Point-and-click network provisioning to support interconnection between branch locations, data centres, cloud providers, and IT services without any hardware requirements.
  • Real-time provisioning of virtual network infrastructure and interconnections.
  • Secure, private hybrid cloud and multicloud connections to more than 360 service providers, 750+ enabled data centres, and 240+ cloud interconnect points.

With more than 80 IT system houses in Germany, Austria, and Switzerland as well as e-commerce companies in 14 European countries, Bechtle offers a blend of direct IT product sales and extensive systems integration services to midsized business, large corporations, and public-sector organisations. Backed by extensive experience and expertise in future-proof IT architecture, Bechtle values traditional infrastructures as well as current trends in digitalisation, cloud computing, modern workplace, security, and IT-as-a-Service.

Megaport helps businesses deploy a global, high-availability network in minutes, not months. Megaport’s NaaS platform provides private, scalable, on-demand connectivity to the world’s leading cloud service providers, such as AWS, Microsoft Azure, and Google Cloud. The company’s solutions enable agile, flexible, high-performance networking for a fraction of the cost of traditional methods.

About Megaport

Megaport is a leading provider of Network as a Service (NaaS) solutions. The company’s global Software Defined Network (SDN) helps businesses rapidly connect their network to services via an easy-to-use portal or our open API. Megaport offers agile networking capabilities that reduce operating costs and increase speed to market compared to traditional networking solutions. Megaport partners with the world’s top cloud service providers, including AWS, Microsoft Azure, and Google Cloud, as well as the largest data centre operators, systems integrators and managed service providers in the world. Megaport is an ISO/IEC 27001-certified company.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Eric Troyer, Chief Marketing Officer, Megaport
Phone: +61 7 3088 7400
media@megaport.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces Positive CHMP Opinion for Opzelura ® (ruxolitinib) Cream for the Treatment of Adults with Moderate Atopic Dermatitis26.6.2026 14:30:00 EEST | Press release

Incyte (Nasdaq: INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Opzelura® (ruxolitinib) cream for the treatment of moderate atopic dermatitis (AD) in adult patients for whom topical corticosteroids (TCSs) and topical calcineurin inhibitors (TCIs) are inadequate or inappropriate. “AD is a chronic skin condition that can have a significant impact on daily life. The positive CHMP opinion for Opzelura marks meaningful progress toward bringing the first non-steroidal topical JAK treatment option to adults in Europe with moderate AD for whom standard topical therapies have failed,” said Lee Heeson, Executive Vice President and Head of Incyte International. “If approved by the European Commission, Opzelura could help address an important gap for patients who have limited treatment options when TCSs and TCIs are inadequate or inappropriate.” The positive CHMP o

Datroway ® Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy26.6.2026 14:00:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been recommended for approval in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the TROPION-Breast02phase 3 trial, which werepresented at the 2025 European Society for Medical Oncology Congress and published in Annals of Oncology. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In TROPION-Breast02, Datroway demonstrated a

DAYBU ® (trofinetide) Recommended for Approval in the European Union by CHMP26.6.2026 13:49:00 EEST | Press release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion following a re-examination procedure, recommending the granting of a marketing authorization for DAYBU® (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older. If granted marketing authorization by the European Commission, DAYBU® would be the first therapy approved for this indication in the European Union (EU). “The CHMP’s positive opinion for DAYBU® is an important milestone in our mission to bring this innovative therapy to the EU, where there are no therapies specifically approved for the neurobehavioral symptoms of this devastating condition," said Catherine Owen Adams, Acadia’s Chief Executive Officer. “Our commitment is to make a meaningful difference in the lives of patients, caregivers, and the wider Rett com

HTEC Showcases Lakebase Branching at Databricks’ Data & AI Summit26.6.2026 12:18:00 EEST | Press release

HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. The Solution was developed in collaboration with a leading risk and compliance technology provider who serves financial institutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260626875859/en/ HTEC, the global technology and AI engineering firm headquartered in Silicon Valley, last week showcased how it used Lakebase data branching to enable faster development, safer operations, and new possibilities for data-driven organizations operating in highly regulated environments. Solving Critical Development Bottlenecks in Regulated Environments At the core of the collaboration was a shared challenge: how to enable modern data workflows in an envi

Stallergenes Greer Named One of Switzerland’s Best Managed Companies for 202626.6.2026 11:28:00 EEST | Press release

Stallergenes Greer, a global leader in allergy care, has been recognised for its overall business performance, company culture, and sustained growth by receiving the prestigious 2026 Switzerland’s Best Managed Companies award. The 2026 Best Managed Companies programme award winners are among Switzerland’s best private companies. The awards are derived from Deloitte’s global Best Managed Companies awards programme, an internationally recognised programme that evaluates businesses based on their leadership in the areas of strategy, culture and commitment, capabilities, innovation, governance and financial performance. Applicants are evaluated by an independent jury of experts. The evaluation of the Switzerland awards is based on more than 30 years of observed practice from the global awards programme that has been rolled out in 50+ countries worldwide. This recognition reflects Stallergenes Greer's consistent ability to deliver on its strategic vision while maintaining the operational di

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye